Sibylla Biotech Alternatives & Competitors
12 companies similar to Sibylla Biotech — Fold the future
Companies similar to Sibylla Biotech
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
San Diego, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Rival Readout
Competing with Sibylla Biotech? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the diffic...
Poland
Degron Therapeutics
Aims to become a global leader in the discovery and development of molecular glue degrader...
San Diego, United States
Celeris Therapeutics
The PIC Engineering Company.
Menlo Park, United States
Cleave Therapeutics, Inc.
VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
San Francisco, United Sta...
Antiverse
Designing functional antibodies for the most challenging targets.
Cardiff, United Kingdom
Gandeeva Therapeutics
Gandeeva Therapeutics uses the most advanced cryo-EM and computational tools to develop be...
Canada
About Sibylla Biotech
Sibylla Biotech, headquartered in Italy, is an innovative contender in the Biotechnology, Health Care, and Pharmaceutical industries, founded in 2017 as a spin-off from the INFN and the Universities of Trento and Perugia. The company stands out for its pioneering Early Drug Discovery method, strategically targeting dis...
Protein Degradation by Folding Interference, AI-Driven Drug Discovery Platform, Development of Small Molecule Therapeutics
Pharmaceutical Companies, Biotechnology Researchers, Medical Research Institutions
Early Drug Discovery, Protein Folding Simulation, Undruggable Targets, PPI-FIT Technology, Pharmacological Protein Inactivation, Folding Intermediate Targeting, Oncology, Antibiotic Resistance, Protein Degradation, Small Molecule Development, Biotech Collaboration, Therapeutic Pipeline Development, Multidisciplinary Team, Computational Biochemistry, Pharmaceutical Partnerships
B2B, Platform, SaaS
Performance Based, Project Based, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Sibylla Biotech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Sibylla Biotech on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 20 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
